Published in Law and Health Weekly, March 8th, 2008
"Today's decision is another affirmation of the strength of the intellectual property behind Lipitor, one of the most important medical breakthroughs of our era," said Pfizer General Counsel Allen Waxman. "The court's ruling reinforces the fundamental principle that patent laws exist to support and encourage...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly